President Joe Biden's administration's push for reviewing marijuana laws aligns with a growing bipartisan support for cannabis reform.
The U.S. Drug Enforcement Administration (DEA) is poised for a groundbreaking move to reclassify marijuana, marking a significant milestone in American drug policy.
Understanding the DEA's Proposal
According to sources, the DEA plans to acknowledge the medical benefits of cannabis and its lower potential for abuse compared to other dangerous drugs. However, this change won't legalize marijuana for recreational use but recognizes its therapeutic value.
Regulatory Implications and Public Feedback
Once approved by the White House Office of Management and Budget (OMB), the DEA will seek public comments on shifting marijuana from Schedule I to Schedule III. This move follows recommendations from the Health and Human Services Department.
Impact on Federal Policies and Public Opinion
President Joe Biden's administration's push for reviewing marijuana laws aligns with a growing bipartisan support for cannabis reform. A recent Gallup poll shows 70% of adults favor legalization, reflecting evolving societal attitudes.
For more information on related topics, consider exploring:
Te puede interesar
Lo más visto
